Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Mar 23, 2017 17.45 +0.35   
 A. Schulman SHLM Mar 23, 2017 31.05 +0.49   
 Aaon Inc AAON Mar 23, 2017 36.35 +2.11   
 Aastrom Biosciences ASTM Mar 23, 2017 2.77 0.00   
 Abaxis Inc ABAX Mar 23, 2017 48.09 -0.74   
 Abengoa S.A. ABGB Mar 23, 2017 1.02 0.00   
 Abeona Therapeutics Inc. ABEOW Mar 23, 2017 3.03 0.00   
 Abeona Therapeutics Inc. ABEO Mar 23, 2017 4.70 -1.05   
 Ability Inc. ABIL Mar 23, 2017 2.34 +0.86   
 Abiomed ABMD Mar 23, 2017 123.75 +0.23   
 Abraxas Petroleum Corp AXAS Mar 23, 2017 2.03 -0.98   
 AC Asia Ex Japan Smallcap MSCI Ishares AXJS Mar 23, 2017 52.38 0.00   
 AC Asia Information Tech MSCI Ishares AAIT Mar 23, 2017 30.53 0.00   
 AC Immune SA ACIU Mar 23, 2017 11.04 -3.75   
 Acacia Communications, Inc. ACIA Mar 23, 2017 56.01 -4.91   
 Acacia Research Corp ACTG Mar 23, 2017 5.25 +1.94   
 Acadia Healthcare Company Inc ACHC Mar 23, 2017 39.57 +0.25   
 Acadia Pharmaceuticals Inc ACAD Mar 23, 2017 34.45 -1.37   
 Acasti Pharma Inc ACST Mar 23, 2017 1.26 -0.79   
 Accelerate Diagnostics Inc AXDX Mar 23, 2017 22.75 0.00   
 Acceleron Pharma Inc XLRN Mar 23, 2017 26.64 -0.78   
 Accelrys Inc ACCL Mar 23, 2017 12.51 0.00   
 Access National Corp ANCX Mar 23, 2017 27.91 +4.34   
 Accuray Incorporated ARAY Mar 23, 2017 4.85 +1.04   
 Acelrx Pharmaceuticals ACRX Mar 23, 2017 3.00 -1.64   
 Aceto Corp ACET Mar 23, 2017 14.89 +2.69   
 Achaogen, Inc. AKAO Mar 23, 2017 20.30 +0.05   
 Achillion Pharmaceuticals ACHN Mar 23, 2017 3.79 -2.07   
 Aci Worldwide ACIW Mar 23, 2017 21.73 +0.14   
 Aclaris Therapeutics, Inc. ACRS Mar 23, 2017 30.23 +2.09   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK